Improve markers of Non-Alcoholic Fatty Liver Disease (NAFLD) or Non-Alcoholic Steatohepatitis (NASH).
Fatty Liver Disease
Archives
- March 2025
- March 2024
- November 2023
- October 2023
- June 2023
- November 2022
- July 2022
- January 2022
- October 2021
- September 2021
- July 2021
- February 2021
- January 2021
- April 2020
- November 2019
- October 2019
- July 2019
- June 2019
- April 2019
- March 2019
- May 2018
- March 2018
- October 2017
- August 2017
- July 2017
- April 2017
- March 2017
- February 2017
- January 2017
- April 2016
- January 2016
- September 2015
- February 2015
- January 2015
- September 2014
- June 2014
- February 2014
- September 2013
- July 2013
- May 2013
- January 2013
- July 2012
- January 2012
- Tirzepatide Once Weekly for the Treatment of Obesity. March 27, 2024
- Establishing that you have something to say September 9, 2015
- NAD+ IV Therapy Benefits: A Complete Guide to Anti-aging Therapy October 23, 2023
- Hangover Survival Guide: Causes, Remedies, and Impact on Health November 2, 2023
- Waking up at early today March 22, 2017
Recently Posted
-
Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders: Exploratory double-blind psychoactive-controlled replication study March 27, 2024 -
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression. March 27, 2024 -
Review of the science and meta-analysis to study the effectiveness of a single dose of ketamine therapy on suicidal ideation. March 27, 2024 -
At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-labeled effectiveness trial. March 27, 2024
